Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Chainlink (LINK) vs Mira (MIRA) Price & Performance

Price performance (Past 24H)

Key statistics

Chainlink vs Mira — how do they compare? Chainlink trades at Rp159,000 (market cap Rp119,03T, Rp4,5T 24h volume), while Mira trades at Rp700.02 (market cap Rp226,43M, Rp101,47M 24h volume). The key difference: Chainlink is far larger — about 525681.2× Mira's market cap, and Chainlink's circulating supply is 748,1M / 1B LINK (75%) versus 321,5M / 1B MIRA (33%) for Mira. Which is the better fit depends on your goals — on Pluang, investors hold Chainlink for 62 Days and Mira for 22 Days on average.

LINKMIRA
Market Cap
Rp119,03TRp226,43M
Volume (24h)
Rp4,5TRp101,47M
Circulating Supply
748,1M / 1B LINK (75%)321,5M / 1B MIRA (33%)
Typical Hold Time
62 Days22 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Chainlink

Chainlink (LINK) is trading at Rp158,860 with a market cap of Rp119.03T, showing bullish technical signals with strong moving average support. The token is approaching resistance at Rp159,591 while maintaining support at Rp155,489. Recent developments include positive regulatory sentiment as former Chainlink executive Taylor Lindman joined the SEC's Crypto Task Force as Chief Counsel in February 2026, potentially benefiting the oracle network's regulatory positioning.

Overall outlook remains cautiously optimistic with technical strength but overbought RSI conditions. Key opportunities include Chainlink's crucial role in bridging blockchain with real-world data, while risks involve regulatory uncertainty and typical crypto volatility. Investors should monitor the Rp159,591 resistance level for breakout confirmation.

Mira

MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.

Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

LINK
43% Buy57% Sell
Avg holding period · 62 Days
MIRA
12% Buy88% Sell
Avg holding period · 22 Days

Top news

Latest headlines on both assets

About Chainlink

Founded in 2017 by Sergey Nazarov , Chainlink is a blockchain abstraction layer that enables universally connected smart contracts. Through a decentralized oracle network, Chainlink allows blockchains to securely interact with external data feeds, events and payment methods, providing the critical off-chain information needed by complex smart contracts to become the dominant form of digital agreement.

Read more on LINK

About Mira

Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.

Read more on MIRA